Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Increased number of FoxP3+CD4+ regulatory T cells in inflammatory bowel disease.

Ban H, Andoh A, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y. Increased number of FoxP3+CD4+ regulatory T cells in inflammatory bowel disease. Mol Med Rep. 2008 Sep-Oct; 1(5):647-50.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.